Erectile Dysfunction

New Drug Enhances Function In Most Men Regardless Of Severity

Published in Drug Week, April 6th, 2001

Men with mild to severe erectile dysfunction (ED) may benefit from Cialis (IC351), an investigational oral treatment for ED, according to a study published in the March 2001 issue of International Journal of Impotence Research.

This first-time publication of detailed Phase II data in a peer-reviewed journal shows that on-demand treatment with Cialis, an advanced phosphodiesterase type 5 (PDE5) inhibitor, improved erections in 81% of men (relative to placebo: 17%), regardless of severity. Cialis is currently in global Phase III studies.

"Cialis is a potent and highly selective PDE5 inhibitor that both increased sexual function and was...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2001-04-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry